Antonio Vena

10.4k total citations · 2 hit papers
173 papers, 4.2k citations indexed

About

Antonio Vena is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Antonio Vena has authored 173 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Infectious Diseases, 79 papers in Epidemiology and 36 papers in Molecular Medicine. Recurrent topics in Antonio Vena's work include Antifungal resistance and susceptibility (60 papers), Antibiotic Resistance in Bacteria (36 papers) and Antibiotic Use and Resistance (34 papers). Antonio Vena is often cited by papers focused on Antifungal resistance and susceptibility (60 papers), Antibiotic Resistance in Bacteria (36 papers) and Antibiotic Use and Resistance (34 papers). Antonio Vena collaborates with scholars based in Italy, Spain and United States. Antonio Vena's co-authors include Matteo Bassetti, Daniele Roberto Giacobbe, Elda Righi, Maddalena Peghin, Antony Croxatto, Benoît Guéry, Emilio Bouza, Patricia Muñóz, Maricela Valerio and Alessandro Russo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Antonio Vena

164 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

How to manage Pseudomonas aeruginosa infections

2018 557 citations Matteo Bassetti, Antonio Vena et al. profile →
Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients

2023 71 citations Małgorzata Mikulska, Chiara Sepulcri et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonio Vena Italy	35	1.9k	1.6k	1.0k	720	597	173	4.2k
Dafna Yahav Israel	41	1.6k 0.8×	1.8k 1.1×	1.3k 1.2×	645 0.9×	1.1k 1.8×	207	5.5k
Francesco Giuseppe De Rosa Italy	36	1.7k 0.9×	2.0k 1.3×	1.6k 1.6×	808 1.1×	1.2k 2.0×	285	5.7k
Garyphallia Poulakou Greece	33	892 0.5×	1.3k 0.8×	1.7k 1.6×	756 1.1×	951 1.6×	106	3.9k
Norio Ohmagari Japan	39	3.7k 2.0×	1.5k 1.0×	1.1k 1.1×	808 1.1×	565 0.9×	509	7.3k
Daniele Roberto Giacobbe Italy	38	1.8k 1.0×	1.9k 1.2×	2.2k 2.1×	1.1k 1.5×	1.4k 2.4×	201	5.2k
Carlo Tascini Italy	38	2.2k 1.2×	1.8k 1.1×	895 0.9×	328 0.5×	648 1.1×	263	5.2k
Jean‐Ralph Zahar France	38	1.5k 0.8×	2.1k 1.3×	1.1k 1.0×	628 0.9×	457 0.8×	154	5.1k
Alessandro Russo Italy	29	961 0.5×	1.2k 0.7×	810 0.8×	473 0.7×	567 0.9×	136	2.9k
Carolina García‐Vidal Spain	47	1.8k 1.0×	3.8k 2.4×	996 1.0×	503 0.7×	534 0.9×	222	6.8k
Sang‐Ho Choi South Korea	46	3.6k 2.0×	3.5k 2.2×	1.2k 1.2×	422 0.6×	646 1.1×	414	8.0k

Countries citing papers authored by Antonio Vena

Since Specialization

Citations

This map shows the geographic impact of Antonio Vena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Vena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Vena more than expected).

Fields of papers citing papers by Antonio Vena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Vena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Vena. The network helps show where Antonio Vena may publish in the future.

Co-authorship network of co-authors of Antonio Vena

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Vena. A scholar is included among the top collaborators of Antonio Vena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Vena. Antonio Vena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giacobbe, Daniele Roberto, Sara Mora, Alessio Signori, et al.. (2025). From Klebsiella and Candida to artificial intelligence: a perspective from infectious diseases doctors and researchers. Frontiers in Medicine. 12. 1676920–1676920. 1 indexed citations

Vena, Antonio, Nadia Castaldo, Daniele Roberto Giacobbe, Alberto Fantin, & Matteo Bassetti. (2025). Omadacycline for the treatment of skin and soft tissue infections. Current Opinion in Infectious Diseases. 38(2). 122–127. 1 indexed citations

Bassetti, Matteo, et al.. (2025). The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies. Current Opinion in Infectious Diseases. 38(2). 114–121. 3 indexed citations

Bassetti, Matteo, et al.. (2024). Rezafungin acetate for the treatment of candidemia and invasive candidiasis: a pharmacokinetic evaluation. Expert Opinion on Drug Metabolism & Toxicology. 21(2). 125–132. 2 indexed citations

Mikulska, Małgorzata, Chiara Sepulcri, Chiara Dentone, et al.. (2023). Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients. Clinical Infectious Diseases. 77(2). 280–286. 71 indexed citations breakdown →

Vena, Antonio, Matteo Bassetti, Francesco Marchesi, et al.. (2023). Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape. Infection. 52(1). 197–208. 9 indexed citations

Esposito, Susanna, Francesco Blasi, Nigel Curtis, et al.. (2023). New Antibiotics for Staphylococcus aureus Infection: An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA). Antibiotics. 12(4). 742–742. 29 indexed citations

Battaglini, Denise, Lorenzo Ball, Antonio Vena, et al.. (2023). Systemic and Cerebral Effects of Physiotherapy in Mechanically Ventilated Subjects. Respiratory Care. 68(4). 452–461. 7 indexed citations

Mascia, Giuseppe, Paolo Di Donna, P. Sartori, et al.. (2023). Long-Term Outcomes of Transvenous Lead Extraction: A Comparison in Patients with or without Infection from the Italian Region with the Oldest Population. Journal of Clinical Medicine. 12(13). 4543–4543. 5 indexed citations

10.

Peghin, Maddalena, Antonio Vena, Elena Graziano, et al.. (2022). Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19. Therapeutic Advances in Infectious Disease. 9. 2008330548–2008330548. 10 indexed citations

11.

Taramasso, Lucia, Laura Magnasco, Federica Portunato, et al.. (2021). Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care. European Journal of Internal Medicine. 94. 39–44. 7 indexed citations

12.

Magnasco, Laura, Małgorzata Mikulska, Daniele Roberto Giacobbe, et al.. (2021). Spread of Carbapenem-Resistant Gram-Negatives and Candida auris during the COVID-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship?. Microorganisms. 9(1). 95–95. 83 indexed citations

13.

Bozzano, Federica, Chiara Dentone, Antonio Di Biagio, et al.. (2021). Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity. PLoS Pathogens. 17(4). e1009448–e1009448. 37 indexed citations

14.

Fenoglio, Daniela, Chiara Dentone, Alessia Parodi, et al.. (2021). Characterization of T lymphocytes in severe COVID‐19 patients. Journal of Medical Virology. 93(9). 5608–5613. 24 indexed citations

15.

Bassetti, Matteo, Antonio Vena, Daniele Roberto Giacobbe, & Nadia Castaldo. (2021). Management of Infections Caused by Multidrug-resistant Gram-negative Pathogens: Recent Advances and Future Directions. Archives of Medical Research. 52(8). 817–827. 29 indexed citations

16.

Bassetti, Matteo, Antonio Vena, Chiara Sepulcri, Daniele Roberto Giacobbe, & Maddalena Peghin. (2020). Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance. Antibiotics. 9(9). 632–632. 48 indexed citations

17.

Vena, Antonio, Daniele Roberto Giacobbe, Nadia Castaldo, et al.. (2020). Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales. Antibiotics. 9(2). 71–71. 76 indexed citations

18.

Valerio, Maricela, Antonio Vena, Carmen Rodríguez, et al.. (2018). Repeated antifungal use audits are essential for selecting the targets for intervention in antifungal stewardship. European Journal of Clinical Microbiology & Infectious Diseases. 37(10). 1993–2000. 20 indexed citations

19.

Bassetti, Matteo, Maddalena Peghin, & Antonio Vena. (2017). Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review. Infectious Diseases and Therapy. 7(1). 17–27. 46 indexed citations

20.

Lagunes, Leonel, Marı́a Gómez, Antonio Vena, et al.. (2016). Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain. European Journal of Clinical Microbiology & Infectious Diseases. 36(1). 95–104. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact